Enter Note Done
Go to previous page in this tab
Event
  • Continuing Education Course
  • Bookmark Icon
  • PM14: The Future Is Here: Practical Implementation of NAMs for Acute Toxicity
  • Schedule
    Notes
  • Set Timezone

Primary Endorser: In Vitro and Alternative Methods Specialty Section


Endorser(s): Occupational and Public Health Specialty Section


Endorser(s): Regulatory and Safety Evaluation Specialty Section


Acute toxicity testing remains one of the most widely conducted sets of studies used for chemical hazard assessment and communication across regulatory sectors, including pesticides, industrial chemicals, antimicrobials, cosmetics, human and veterinary pharmaceuticals, and consumer products. Acute toxicity data underpin such things as classification and labeling and worker and consumer protection measures for a plethora of products. At the same time, substantial scientific, ethical, and regulatory momentum has driven the development of new approach methodologies (NAMs) to reduce or replace traditional animal-based acute toxicity testing while maintaining health protective outcomes.

This course is designed to educate participants on how acute toxicology is being practically modernized through the application of NAMs and how these approaches are being implemented across sectors with differing regulatory drivers, product types, exposure scenarios, and legal frameworks. Participants will gain a clear understanding of why acute toxicity data are still required, who relies on these data, and how NAM-based strategies can meet regulatory information needs for occupational, consumer, and public health protection.

The course begins by establishing a common foundation, including the historical role of acute toxicity testing, the scale of animal use associated with traditional approaches, and the scientific basis for emerging in vitro, in silico, and defined approaches. Speakers will address validation and reliability challenges, uncertainty management, and the continued influence of legacy animal data on regulatory confidence. Regulatory perspectives from the United States and Canada will illustrate how NAMs are being implemented within existing pesticide frameworks to support protective classification and labeling decisions. Applied case studies will demonstrate how NAM-based strategies are assembled in practice, including an antimicrobial formulation example highlighting waiver rationales, weight of evidence integration, and jurisdictional differences, and success stories from the cosmetic sector illustrating mature use of NAMs.

By the conclusion of this course, participants will be able to describe the regulatory, scientific, and retail drivers for modernizing acute toxicity testing across multiple sectors; compare traditional animal-based approaches with validated and emerging NAM-based strategies for key acute toxicity endpoints; evaluate the strengths, limitations, and appropriate application of NAMs for protection-focused hazard characterization; and apply practical principles for assembling transparent, scientifically sound, and health protective acute toxicity justifications that reduce reliance on animal testing while meeting sector-specific regulatory expectations.

Session and Activity Type
Presentations